PRN: Global Anatomic Pathology Testing Market to Grow at a CAGR of 8.26% by 2021 - Driven by the Growing Prevalence of Cancer in Demographics - Research and Markets

21/mar/2017 14:15:11 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Anatomic Pathology Testing Market to Grow at a CAGR of 8.26% by 2021 - Driven by the Growing Prevalence of Cancer in Demographics - Research and Markets


DUBLIN, Mar 21, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Anatomic Pathology Testing Market 2017-2021" report to their offering.

Research and Markets Logo

The global anatomy pathology testing market to grow at a CAGR of 8.26% during the period 2017-2021.

The report, Global Anatomic Pathology Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

The small companies and new players in the market approach venture capitalists to develop anatomic pathology testing products. These capitalists have realized the significant potential these companies have to develop innovative technologies and products in the area of immunohistochemistry and cytology for diagnosis of chronic diseases such as cancer. This has increased the financial flow support from venture capitalists, which is accelerating the development of anatomic pathology testing market. Post registration and market approval, venture capitalists take a share from the total revenue generated by these companies.

According to the report, the personalized medicine is individualized to treat chronic diseases. Since each individual has unique pathology and physiology; to customize the treatment plan, personalized medicines are used. In such cases, the proteins and genes in cells of tissues, which control various functions of the body are tested. A defect in a particular protein or gene structure can result in specific conditions and disorders. Anatomic pathology helps to understand the cellular framework of the individual, which is important for developing a personalized treatment. The development of personalized medicine depends on the identification and study of these defective proteins and genes extracted from tissues.

Key vendors:

  • Abbott Diagnostics
  • Agilent Technologies
  • Danaher
  • Roche Diagnostics
  • Thermo Fisher Scientific

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Market segmentation by products

PART 07: Market segmentation by application

PART 08: Market segmentation by end-user

PART 09: Geographical segmentation

PART 10: Market drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape

PART 16: Key vendor analysis

PART 17: Appendix

For more information about this report visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


blog comments powered by Disqus è un servizio offerto da Factotum Srl